Thai Cannabis GACP Evidence: What Buyers Actually Need

GACP covers growing, collection and primary processing of herbal starting materials. For cannabis, that means the farm must prove how the plant material was produced, handled and protected from contamination before it enters a pharmaceutical route.

A buyer cannot responsibly evaluate a Thai farm from a license and a lab COA alone. The useful question is whether the farm can reconstruct one batch from genetics and cultivation inputs through harvest, drying, trimming, storage, sampling and release to the next party.

Evidence becomes useful when it is contemporaneous, attributable, complete and tied to a named batch. A folder full of generic SOPs is not enough. Buyers need to see whether the SOP was followed and whether exceptions were captured.

CannaWorld should position the platform as an evidence operating system: it organizes and pressure-tests records, but it does not replace the buyer's own qualification, importer responsibility, QP review or authority decision.

A farm is not ready for serious EU-facing review if batch identity is reconstructed after the fact, if pesticide controls are informal, if drying rooms have no environmental logs, or if staff training cannot be linked to the tasks they performed.

A farm can still be commercially interesting if the gaps are clear, bounded and fixable. The first output should be a route feasibility decision: ready, conditional, or blocked.